Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: • Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; • The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; • Disruptions or inefficiencies in our supply chain, logistics, or operations; • Changes in laws and regulations in jurisdictions where we conduct business, including with respect to plastics and climate change; • Fluctuations in raw material prices, quality and supply, and in energy prices and supply; • Demand for our products and services; • Production outages or material costs associated with scheduled or unscheduled maintenance programs; • Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; • Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends; • Information systems failures and cyberattacks; • Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; • Our ability to achieve strategic objectives and successfully integrate acquisitions, including the implementation of a cloud-based enterprise resource planning system, S/4HANA; • Other factors affecting our business beyond our control, including without limitation, changes in the general economy, changes in interest rates, changes in the rate of inflation, geopolitical conflicts and any recessionary conditions; and • Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2023 under Item 1A, “Risk Factors.”FX +8.5% FX -0.4% Total Avient +8.1% Note: Regional Sales Percentages exclude impact of foreign exchange COLOR, ADDITIVES & INKS SEGMENT $487 $522 $89 $97 (in millions) (in millions) 7 + 7% (+8% excluding FX) + 9% (+11% excluding FX) 18.3% +40 bps *18.7% * * Adjusted EBITDA Margin % • Sales growth driven by winning new product specifications in consumer & packaging, strong underlying demand in healthcare and improving demand in building & construction • Favorable mix and raw material deflation contributed to EBITDA margin expansion SPECIALTY ENGINEERED MATERIALS SEGMENT $268 $295 $51 $57 (in millions) (in millions) 8 • Sales growth driven by restocking in healthcare & consumer end markets and strong underlying demand for composite applications used in building & construction, energy and defense end markets • Favorable mix contributed to EBITDA margin expansion + 10% (+10% excluding FX) + 12% (+13% excluding FX) 19.0% +40 bps *19.4% * * Adjusted EBITDA Margin % 2024 G U IDA N CE FY 2024 GUIDANCE Previous (Aug 6) Current Adjusted EPS $2.55 to $2.70 $2.63 to $2.67 Adjusted EBITDA $515 to $540 million $525 to $530 million Interest Expense $105 million $104 million Adjusted Effective Tax Rate 23% to 25% 23% to 25% Capital Expenditures & Investment in S/4 Hana ~$140 million ~$140 million 10 11 • Investor Day to be held 2024年12月4日 at the NYSE, beginning at 10AM • The focus will be to do a deep dive on the Company’s strategy • Registration and microsite will be available in early November 2024 AVIENT INVESTOR DAY AP P EN D IX 18 Performance Additives 15% Pigments TiO2 Dyestuffs Polyethylene 10%Nylon Polypropylene Styrenic Block Copolymer Other Raw Materials 38% ~40% hydrocarbon based (Grey shaded materials are hydrocarbon based, includes portion of “Other Raw Materials”) Non-hydrocarbon based materials RAW MATERIAL BASKET SEGMENT DATA U.S. & Canada 41% 36% 2023 SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS 19% 23%Industrial Building and 7% END MARKET REVENUE $2,007M $358M $1,138M $224M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $502M$3,143M (1) 7% 20 (1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs 2023 REVENUE | $2 .0 B ILL ION 34% 37% 21% END MARKET REGION 21 34% 21% 15% Building & 1% Energy COLOR, ADDITIVES & INKS 2023 REVENUE | $1 .1 B ILL ION 52% 35% 22 6%Industrial 12% 10% Defense Building & END MARKET REGION SPECIALTY ENGINEERED MATERIALS 32% 26% Building & 6% 2% Defense 1% (18% of sales) 2023 AVIENT REGIONAL SALES 25% Building & (36% of sales)Transportation 22% Building & 12% 6% US & Canada (41% of sales) 59% 22% Building & LATAM (5% of sales) 23 BY END MARKET Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. A reconciliation of these measures to their most directly comparable GAAP measures is provided in the tables below. 2024 2023 Reconciliation to Condensed Consolidated Statements of Income $ EPS(1) $ EPS(1) Net income from continuing operations attributable to Avient shareholders $ 38.2 $ 0.41 $ 5.1 $ 0.06 Special items, after-tax 6.6 0.07 32.0 0.35 Amortization expense, after-tax 15.0 0.16 15.2 0.16 Adjusted net income / EPS $ 59.8 $ 0.65 $ 52.3 $ 0.57 (1) Per share amounts may not recalculate from figures presented herein due to rounding Three Months Ended Reconciliation to EBITDA and Adjusted EBITDA: 2024 2023 Net income from continuing operations – GAAP $ 38.7 $ 5.1 Income tax expense (benefit) 11.3 (0.1) Interest expense, net 26.9 30.3 Depreciation & amortization 45.1 46.4 EBITDA from continuing operations $ 122.0 $ 81.7 Special items, before tax 9.7 43.2 Interest expense included in special items (1.3) (2.2) Depreciation & amortization included in special items (0.4) — Adjusted EBITDA $ 130.0 $ 122.7 Adjusted EBITDA as a percent of sales 15.9 % 16.3 % 1 2024 2023 Sales: Color, Additives and Inks $ 521.5 $ 486.5 Specialty Engineered Materials 294.6 267.9 Corporate (0.9) (0.7) Sales $ 815.2 $ 753.7 Operating income: Color, Additives and Inks $ 75.5 $ 64.5 Specialty Engineered Materials 36.4 30.3 Corporate (34.7) (60.5) Operating income $ 77.2 $ 34.3 Depreciation & amortization: Color, Additives and Inks $ 21.9 $ 24.6 Specialty Engineered Materials 20.7 20.5 Corporate 2.5 1.3 Depreciation & amortization $ 45.1 $ 46.4 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 97.4 $ 89.1 Specialty Engineered Materials 57.1 50.8 Corporate (32.2) (59.2) Other (expense) income, net (0.3) 1.0 EBITDA from continuing operations $ 122.0 $ 81.7 Special items, before tax 9.7 43.2 Interest expense included in special items (1.3) (2.2) Depreciation & amortization included in special items (0.4) — Adjusted EBITDA $ 130.0 $ 122.7 Adjusted EBITDA as a percent of sales: Color, Additives and Inks 18.7 % 18.3 % Specialty Engineered Materials 19.4 % 19.0 % 2 Year Ended December 31, 2023 Operating income: Color, Additives and Inks $ 259.9 Specialty Engineered Materials 142.5 Corporate (205.6) Operating income $ 196.8 Depreciation & amortization: Color, Additives and Inks $ 98.3 Specialty Engineered Materials 81.5 Corporate 9.0 Depreciation & amortization $ 188.8 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 358.2 Specialty Engineered Materials 224.0 Corporate (196.6) Other income, net 5.8 EBITDA from continuing operations 391.4 Special items, before tax 114.6 Interest expense included in special items (2.3) Depreciation & amortization included in special items (1.9) Adjusted EBITDA $ 501.8 3 Avient Q3 Earnings Webcast Slides w_Appendix and Non-GAAP.pdf 2024 AVNT Q3 Webcast Slides w non-GAAP.pdf Q3 Avient Webcast Slides with Non-GAAP Recs.pdf Appendix Slides for webcast.pdf IR Deck - AVNT-2024.09.30 - 10.30.24 3PM (002).pdf Attachment

LoC No: 798019/2023 Page 1 of 1 Letter of Conformity Good Manufacturing Practices — Guidelines The Letter of Conformity is granted to Polyone Polymers India Private Limited Plot No. F -27, MIDC, Ranjangaon, Taluka – Shirur, Pune Maharashtra 412220 India Hold this Opinion Statement No. 798019/2023 The Organization has demonstrated that they have followed the guidelines provided for Good Manufacturing Practices as per the ICHQ7 guidelines in their organization for the following Business activity: Research and Development, Manufacture of Color additives, Concentrates and Specialty Formulations for intended use in pharma and other industries Theuns Kotze, Managing Director – IMETA Assurance Last Audit Date: 31.10.2023 BSI Group India Private Limited T: +91-4762-9000 (CIN U74899DL1999PTC101381 info.in@bsigroup.com The Mira Corporate Suites bsigroup.com/en-IN Plot 1&2, Ishwar Nagar, Mathura Road New Delhi-110065, India

View PDF The SQS herewith attests that the organisation named below has a management system that meets the requirements of the normative base mentioned. 70 01 _1 /A pr il 20 22 /V er si on 2 .0 Certificate Avient Colorants Germany GmbH Hohenrhein 1 56112 Lahnstein Germany Scope Production of Color Concentrates and Compounds Normative base ISO 50001:2018 Energy Management System Reg. no. 46089 Page 1 of 1 Validity 17. 12. 2023  – 16. 12. 2026 Issue 17. 12. 2023  A.Grisard, President SQS F.

Rev 12-05-2023 Avient Corporation: Quality Response for Manufacturing Facilities in North America, North LATAM, Europe, the Middle East, and Africa 2 Dear Customer, This Quality Response for Manufacturing Facilities in North America, Europe, the Middle East and Africa, is being provided in response to your request to complete and return your supplier questionnaire / assessment. We thank you for your understanding, and we look forward to serving your needs. 3 Table of contents A Message from our Global Quality Manager ...............................................................2 Avient Corporation: Overview ............................4 Avient Policy for Customer Audits ......................5 Management Responsibility ...............................6 Product Liability Insurance .............................6 Ethics - Code of Conduct.................................6 Modern Slavery Statement.............................6 Conflict Mineral Policy....................................6 Technical Data Sheets.....................................6 Safety Data Sheets..........................................6 Regulatory Requests and Certificates (FDA certificate, Absence declaration, REACH, SDS) ........................................6 Safety Performance ........................................6 Environmental Performance...........................6 Energy Management ......................................6 Business Continuation Plan.............................6 Preventive - Predictive Maintenance..............6 Financial Report..............................................6 Quality Management..........................................7 3rd Party Certification......................................7 Complaint Handling ........................................7 Continuous Improvement...............................7 Traceability .....................................................7 Record Retention............................................7 IT Security.........................................................8 Firewall .........................................................8 Critical Data ..................................................8 IT Disaster Recovery .....................................8 IT Systems of Use Policy ...............................8 Annex 1 - Special dispositions related to ISO 13485 certification for Mevopur .......................9 Change control .............................................9 Validation .....................................................9 Control of documents and records ...............9 Supplier approval and supplier evaluation ...9 Traceability ...................................................9 Material management ..................................9 Release of finished products.........................9 Control of Non-conforming products, complaints handling, recall and CAPA..........9 Annex 2 – special dispositions related to ISO 22000 certification............................................10 Change..........................................................10 HACCP ..........................................................10 Control of documents and records ...............10 Material management ..................................10 Supplier approval and supplier evaluation ...10 Traceability ...................................................10 Release of finished products.........................10 Control of Non-conforming products, complaints handling, recall and CAPA..........10 4 Avient Corporation: Overview The Avient website is your home base for information about the company: https://www.avient.com/ To find our facility locations: https://www.avient.com/contact/global-directory-and-contacts For more information about our management systems certifications, including ISO, go to: Avient Governance (corporate policies and the Avient Code of Conduct): https://www.avient.com/investors/governance Financial reports: https://www.avient.com/investors Avient Sustainability Report: https://www.avient.com/company/sustainability https://www.avient.com/ https://www.avient.com/contact/global-directory-and-contacts https://www.avient.com/investors/governance https://www.avient.com/investors https://www.avient.com/company/sustainability 5 Avient Policy for Customer Audits Avient may permit audits of facilities, subject to:  Advanced notice and an audit agenda provided at least thirty (30) days in advance or as agreed by the Avient location to be audited for a routine audit Standard handling time frame: 1 Business Day to confirm receipt and r .ecord it in our system 15 Business days to analyze problem, provide root cause and action plan. 30 days to close complaint 8 The overall processing times may vary depending on the complexity of the issue and resources needed.

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation Page 4 • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth • 17 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Steve Newlin Appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2013 2014 and beyond -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $38.38 March 7th, 2014 • 17 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 5 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% United States 66% Europe 14% Canada 7% Asia 6% Latin America 7% PP&S Specialty 53% Distribution 27% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target Ad ju st ed E ar ni ng s P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 6 PolyOne At A Glance Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 65- 75% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty Specialty OI $5M $46M $87M $195M Target Mix Shift Highlights Specialty Transformation 2015 Target Page 7 2006 2013 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 12.2% 12 – 16% Global Specialty Engineered Materials 1.1% 9.3% 12 – 16% Designed Structures & Solutions -- 5.6% 8 – 10% Performance Products & Solutions 5.4% 7.2% 9 – 12% Distribution 2.6% 5.9% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 62% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.1% 15% 4) Adjusted EPS Growth N/A 31% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Page 8 Bridge To $2.50 Adjusted EPS By 2015 2015 EPS: $2.50 2013 EPS: $1.31 Mid single digit revenue CAGR Page 9 Mergers & Acquisitions Spartech accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 10 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 Healthcare Consumer Packaging and Additive Technology Transportation Page 11 Unique and Innovative Solutions that Help Customers Win https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG Net Debt / EBITDA* = 1.8x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Significant Debt Maturities As of 2013年12月31日 ($ millions) Page 12 Coupon Rates: 7.500% 7.375% 5.250% Debt Maturities & Pension Funding – 12/31/13 *TTM 12/31/2013 ** includes US-qualified plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2013 Pension Funding** As of 2013年12月31日 Free Cash Flow and Strong Balance Sheet Fund Investment •Targets that expand our: • Specialty offerings •End market presence •Geographic footprint •Operating Margin • Synergy opportunities •Adjacent material solutions •Expanding our sales, marketing, and technical capabilities • Investing in operational and LSS initiatives (including synergy capture) •Manufacturing alignment Organic Growth Share Repurchases Dividends Acquisitions Page 13 $0.16 $0.20 $0.24 $0.32 $0.00 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend • Repurchased ~5 million shares in 2013 • 15 million shares are available for repurchase under the current authorization The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Why Invest In PolyOne?

Additionally, Adjusted EPS excludes the impact of special items and amortization expense associated with intangible assets.2 T RAN S FO R MAT IO NAL OVE RV IE W Avient Protective Materials Dyneema ® RECENT TRANSACTIONS Acquired Divested $1.45 B $0.95 B 4 Distribution UPDATED CAPITAL STRUCTURE & LIQUIDITY • Proceeds from completed sale of Distribution used to pay near-term maturing debt to strengthen balance sheet • Fixed/floating debt ratio of ~55/45 • Proven track record of deleveraging following major acquisitions through strong free cash flow generation • 2022 pro forma net debt/adjusted EBITDA expected to be 3.1x $725 $725 $575 $500 $600 $525 $650 $650 $600 Capital Structure Cash $544 Undrawn Revolver $250 Liquidity $3.15B $2.40B 2030 Notes 2029 Term Loan 2026 Term Loan 2025 Notes 2023 Notes After Dyneema Acquisition After Distribution Divestiture $794M (1) $250M reflects estimated undrawn revolver following the divestiture of Distribution 5 PREVIOUS TRANSACTIONS Performance Solutions Products & $0.8 B COLOR $1.4 B Acquired (2020)Divested (2019) 6 • Acquisition of Clariant Color business significantly expanded presence in healthcare, packaging and consumer end markets • Strength of portfolio – double-digit annual EBITDA growth since acquisition • $75 million of realized synergies anticipated in 2022 • Acquisition completed on 2020年7月1日 for $1.45 billion. Three Months Ended September 30, 2022 Three Months Ended September 30, 2021 Reconciliation to Condensed Consolidated Statements of Income $ EPS $ EPS Net (loss) income from continuing operations attributable to Avient shareholders $ (27.4) $ (0.30) $ 33.7 $ 0.37 Special items, after tax (Attachment 3) 68.3 0.75 11.7 0.13 Amortization expense, after-tax 13.4 0.14 $ 11.0 $ 0.11 Adjusted net income / EPS $ 54.3 $ 0.59 $ 56.4 $ 0.61 2009* 2012* 2015 2018 Net income from continuing operations attributable to Avient common shareholders $ 106.7 $ 53.3 $ 144.6 $ 161.1 Joint venture equity earnings, after tax (19.0) — — — Special items, before tax (48.7) 55.1 87.6 59.5 Special items, tax adjustments (27.2) (18.9) (58.7) (25.3) Amortization expense, after tax 1.8 8.3 10.4 19.5 Adjusted net income from continuing operations attributable to Avient common shareholders $ 13.6 $ 97.8 $ 183.9 $ 214.8 Diluted shares 93.4 89.8 88.7 80.4 Adjusted EPS attributable to Avient common shareholders $ 0.15 $ 1.09 $ 2.08 $ 2.67 * Historical results have been updated to reflect subsequent changes to accounting principle and discontinued operations, excluding any changes as a result of discontinued operations from the sale of the Designed Structures and Solutions segment (DSS) and the Performance Products and Solutions segment (PP&S). 1 Year Ended December 31, Reconciliation to EBITDA and Adjusted EBITDA: 2006 2018 Sales $ 2,622.4 $ 3,533.4 Net income from continuing operations – GAAP $ 133.5 $ 160.8 Income tax expense 29.7 36.4 Interest expense 63.1 62.8 Depreciation and amortization 57.1 91.5 EBITDA $ 283.4 $ 351.5 Special items, before tax (34.0) 59.5 Depreciation and amortization included in special items — (3.0) JV - equity income (107.0) — Adjusted EBITDA $ 142.4 $ 408.0 EBITDA as a % of sales 5.4 % 11.5 % Reconciliation of Color, Additives and Inks EBITDA Operating Income 68.6 66.8 Depreciation and amortization 24.2 26.6 EBITDA 92.8 $ 93.4 Reconciliation of Specialty Engineered Materials EBITDA SEM(1) Pro forma APM(1) Pro forma SEM SEM Pro forma APM Pro forma SEM Operating Income 31.4 6.3 37.7 30.0 13.9 43.9 Depreciation and amortization 12.9 10.9 23.8 7.9 18.4 26.3 EBITDA $ 44.3 $ 17.2 $ 61.5 $ 37.9 $ 32.3 $ 70.2 Reconciliation of Specialty Engineered Pro Forma Sales Sales 258.2 231.7 Pro forma APM(1) 60.7 94.1 Pro forma sales $ 318.9 $ 325.8 Reconciliation of Avient Pro Forma Sales Sales 823.3 818.0 Pro forma APM(1) 60.7 94.1 Pro forma sales $ 884.0 $ 912.1 (1) - Q3 2022 SEM results reflect one month of APM’s results while owned by Avient, as the acquisition closed on 2022年9月1日.

Buyer must give Seller written notice of the existence of each claim involving Product (whether based in contract, breach of warranty, negligence, strict liability, other tort or otherwise) within the earlier of thirty (30) days after receipt of the quantity of Product forming the basis for the claim or applicable shelf-life expiration, if any. i) If Buyer is in default of performance of its obligations towards Seller and fails to provide adequate assurance of Buyer’s performance before the date of scheduled delivery; or (ii) if Seller has reasonable doubts with respect to Buyer’s performance of its obligations and Buyer fails to provide to Seller adequate assurance of Buyer’s performance before the date of scheduled delivery and in any case within thirty (30) days of Seller’s demand for such assurance; or (iii) if Buyer becomes insolvent or unable to pay its debts as they mature, or goes into liquidation or any bankruptcy proceeding shall be instituted by or against Buyer or if a trustee or receiver or administrator is appointed for all or a substantial part of the assets of Buyer or if Buyer makes any assignment for the benefit of its creditors; or (iv) in case of non- compliance of Buyer with any law, statute ordinance, regulation, code or standard (“Laws and Standards”), then Seller may by notice in writing to Buyer, without prejudice to any of its other rights: (a) demand return and take repossession of any delivered Products which have not been paid for and all costs relating to the recovery of the Products shall be for the account of Buyer; and/or (b) suspend its performance or terminate its order confirmation for pending delivery of Products unless Buyer makes such payment for Products on a cash in advance basis or provides adequate assurance of such payment for Products to Seller. Terms and Conditions (July 1, 2023)

MC-73053PE ALBA PEARL 30% WHITER

BLUE W/PEARL +30

Pebax 7433 Med, 30% BaSO4, 2% TiO2